Abstract
Purpose The aim of the present study was to evaluate the clinical outcome after Descemet membrane endothelial keratoplasty (DMEK) in eyes with previous vitrectomy. Patients and methods This is a retrospective review of medical records and surgical videos of all DMEK cases in vitrectomized eyes (total or anterior vitrectomy) that were done at Alexandria Main University Hospital, Alexandria, Egypt, between January 2015 and November 2019. The primary outcome measure was the improvement in best-corrected visual acuity. Secondary outcome measures were unfolding time and technique, endothelial cell loss, and rebubbling rate. Results A total of 18 vitrectomized eyes of 18 patients with bullous keratopathy were included in this study. Follow-up duration ranged from 6 to 53 months, with a mean of 23.8±15.2 months. At the end of the follow-up, the best-corrected visual acuity improved from 1.9±0.5 log MAR units to 0.7±0.4 log MAR units. The mean endothelial cell density was 1136.6±204.4 cells/mm2, representing 53% loss of the mean preoperative donor endothelial cells (2388.3±114.8 cells/mm2). The mean graft unfolding time was 13.7±5.4 min. A total of 11 (61%) eyes needed rebubbling owing to postoperative Descemet membrane detachment. Conclusion DMEK is an effective surgical modality for treatment of bullous keratopathy in vitrectomized eyes. Restoration of corneal clarity and significant visual improvement were possible in all patients, despite the need for complex surgical steps, prolonged surgical time, and the increased rebubbling rate.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.